BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27702824)

  • 21. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
    Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
    Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain metastasis of Wilms tumor with diffuse anaplasia and complex cytogenetic phenotype in a child with neurofibromatosis Type 1.
    Shvartsbeyn M; Bassani L; Mikolaenko I; Wisoff JH
    J Neurosurg Pediatr; 2011 Oct; 8(4):353-6. PubMed ID: 21961578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S
    J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
    Cost NG; Mitui M; Khokhar S; Wickiser JE; Baker LA; Rakheja D
    Pediatr Blood Cancer; 2012 Aug; 59(2):326-8. PubMed ID: 22052810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaplasia in Wilms tumor: A critical review.
    Vujanić GM; Mifsud W
    Pediatr Blood Cancer; 2024 Apr; ():e31000. PubMed ID: 38605554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between TP53 Mutation and Prognosis in Wilms Tumor: A Meta-Analysis.
    Lizhi L; Rongdong H; Shaohua H; Yingquan K; Huihuang X; Shan L; Kunbin T; Di X
    Fetal Pediatr Pathol; 2021 Dec; 40(6):653-662. PubMed ID: 32066305
    [No Abstract]   [Full Text] [Related]  

  • 27. New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience.
    Vujanić GM; Harms D; Sandstedt B; Weirich A; de Kraker J; Delemarre JF
    Med Pediatr Oncol; 1999 May; 32(5):317-23. PubMed ID: 10219330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
    Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
    Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.
    Hamilton TE; Green DM; Perlman EJ; Argani P; Grundy P; Ritchey ML; Shamberger RC
    J Pediatr Surg; 2006 Oct; 41(10):1641-4. PubMed ID: 17011261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2.
    Lovvorn HN; Renfro LA; Benedetti DJ; Kotagal M; Phelps HM; Ehrlich PF; Lo AC; Sandberg JK; Treece AL; Gow KW; Glick RD; Davidoff AM; Cost NG; Dix DB; Fernandez CV; Dome JS; Geller JI; Mullen EA
    J Am Coll Surg; 2024 Apr; 238(4):733-749. PubMed ID: 38251681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of P53 protein in nephroblastoma: a predictor of unfavorable prognosis.
    Morgan ED; Yahaya JJ; Ngaiza AI; Othieno E; Livex OA
    J Egypt Natl Canc Inst; 2023 Jul; 35(1):23. PubMed ID: 37518096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.
    Wittmann S; Zirn B; Alkassar M; Ambros P; Graf N; Gessler M
    Genes Chromosomes Cancer; 2007 Feb; 46(2):163-70. PubMed ID: 17099873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.
    Hazen-Martin DJ; Re GG; Garvin AJ; Sens DA
    Am J Pathol; 1994 May; 144(5):1023-34. PubMed ID: 8178926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.
    Woods AD; Berlow NE; Ortiz MV; Dela Cruz F; Siddiquee A; Coutinho DF; Purohit R; Freier KET; Michalek JE; Lathara M; Matlock K; Srivivasa G; Royer-Pokora B; Veselska R; Kung AL; Keller C
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29401. PubMed ID: 34693628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of prognostic and predictive aspects of mutated TP53 in Wilms' tumor biology with morphological report and molecular analysis of 37-year-old man's nephroblastoma.
    Wincewicz A; Kowalik A; Zięba S; Kopczyński J; Góźdź S; Sulkowski S
    Pol J Pathol; 2016; 67(4):307-312. PubMed ID: 28547957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple mechanisms of MYCN dysregulation in Wilms tumour.
    Williams RD; Chagtai T; Alcaide-German M; Apps J; Wegert J; Popov S; Vujanic G; van Tinteren H; van den Heuvel-Eibrink MM; Kool M; de Kraker J; Gisselsson D; Graf N; Gessler M; Pritchard-Jones K
    Oncotarget; 2015 Mar; 6(9):7232-43. PubMed ID: 25749049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological analysis of aggressiveness and responsiveness in Wilms' tumor.
    Beckwith JB; Zuppan CE; Browning NG; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):422-8. PubMed ID: 8827069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.